Goal-directed haemodynamic therapy: what else? Comment on Br J Anaesth 2022; 128: 416-33
- PMID: 35131095
- DOI: 10.1016/j.bja.2022.01.011
Goal-directed haemodynamic therapy: what else? Comment on Br J Anaesth 2022; 128: 416-33
Keywords: goal-directed haemodynamic therapy; haemodynamic monitoring; personalised medicine; postoperative complications; randomised controlled trial.
Conflict of interest statement
Declarations of interest FM is the managing director of MiCo, a Swiss consulting and research company. MiCo does not sell any medical devices, and FM does not own shares nor receive patent royalties from any medical device company. EF declares consulting fees from Dräger Medical, GE Healthcare, Edwards Lifesciences, and Orion Pharma, and lecture fees from Fresenius Kabi and Getinge. AJ is a consultant for Edwards Lifesciences, Aguettant Laboratories, and Fresenius Kabi.
Comment on
-
Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis.Br J Anaesth. 2022 Mar;128(3):416-433. doi: 10.1016/j.bja.2021.10.046. Epub 2021 Dec 13. Br J Anaesth. 2022. PMID: 34916049 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources